| Metric | FY 2024↕ | FY 2023↕ |
|---|---|---|
| Revenue | — | — |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| R&D Expense | — | — |
| SG&A Expense | — | — |
| Operating Income | — | — |
| Net Income | $0.0B | $0.0B |
| EPS (Basic) | $1.07 | $0.23 |
| EPS (Diluted) | $1.07 | $0.23 |
| Metric | FY 2024↕ | FY 2023↕ |
|---|---|---|
| Total Assets | $5.2B | $4.5B |
| Current Assets | — | — |
| Cash & Equivalents | — | — |
| Total Liabilities | $4.4B | $3.8B |
| Current Liabilities | — | — |
| Stockholders' Equity | $0.8B | $0.8B |
| Metric | FY 2024↕ | FY 2023↕ |
|---|---|---|
| Operating Cash Flow | $0.0B | $0.1B |
| Investing Cash Flow | $-0.5B | $-0.8B |
| Capital Expenditures | $0.0B | $0.0B |
| Financing Cash Flow | $0.6B | $0.9B |